95 related articles for article (PubMed ID: 24192519)
1. Endocervical-like versus intestinal-type mucinous borderline ovarian tumors: a large retrospective series focusing on the clinicopathologic characteristics.
Song T; Choi CH; Lee YY; Kim TJ; Lee JW; Sung CO; Song SY; Bae DS; Kim BG
Gynecol Obstet Invest; 2013; 76(4):241-7. PubMed ID: 24192519
[TBL] [Abstract][Full Text] [Related]
2. [The clinicopathological features and risk factors of recurrence in patients with mucinous borderline ovarian tumors].
Sun L; Song Y; Li N; Yuan GW; Sun YC; Li N; Ma SK; Zhang X; Wu LY
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):589-594. PubMed ID: 28835081
[No Abstract] [Full Text] [Related]
3. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
[TBL] [Abstract][Full Text] [Related]
4. Recurrent intestinal mucinous borderline tumors of the ovary: a report of 5 cases causing problems in diagnosis, including distinction from mucinous carcinoma.
Irving JA; Clement PB
Int J Gynecol Pathol; 2014 Mar; 33(2):156-65. PubMed ID: 24487471
[TBL] [Abstract][Full Text] [Related]
5. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
[TBL] [Abstract][Full Text] [Related]
6. Prognosis in patients with serous and mucinous stage I borderline ovarian tumors.
Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
Int J Gynecol Cancer; 2012 Jun; 22(5):770-7. PubMed ID: 22426410
[TBL] [Abstract][Full Text] [Related]
7. Borderline ovarian tumours: retrospective analysis of twenty-one cases.
Saygili U; Uslu T; Erten O; Doğan E
Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063
[TBL] [Abstract][Full Text] [Related]
8. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
9. Endocervical-like mucinous borderline tumors of the ovary: clinicopathological features and electron microscopic findings.
Moriya T; Mikami Y; Sakamoto K; Endoh M; Takeyama J; Suzuki T; Mochizuki S; Watanabe M; Monobe Y; Sasano H
Med Electron Microsc; 2003 Dec; 36(4):240-6. PubMed ID: 16228656
[TBL] [Abstract][Full Text] [Related]
10. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
[TBL] [Abstract][Full Text] [Related]
11. Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary.
Halimi SA; Maeda D; Shinozaki-Ushiku A; Koso T; Matsusaka K; Tanaka M; Arimoto T; Oda K; Kawana K; Yano T; Fujii T; Fukayama M
Histopathology; 2013 Oct; 63(4):534-44. PubMed ID: 23905715
[TBL] [Abstract][Full Text] [Related]
12. High-risk borderline ovarian tumors: analysis of clinicopathological features and prognostic impact of different follow-up strategies.
Lorusso D; Ratti M; Ditto A; Raspagliesi F
Oncology; 2014; 87(3):183-92. PubMed ID: 25033912
[TBL] [Abstract][Full Text] [Related]
13. Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases.
Muyldermans K; Moerman P; Amant F; Leunen K; Neven P; Vergote I
Eur J Cancer; 2013 May; 49(7):1600-8. PubMed ID: 23321546
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic Features and Risk Factors for Recurrence of Mucinous Borderline Ovarian Tumors: A Retrospective Study With Follow-up of More Than 10 Years.
Sun L; Li N; Song Y; Wang G; Zhao Z; Wu L
Int J Gynecol Cancer; 2018 Nov; 28(9):1643-1649. PubMed ID: 30365456
[TBL] [Abstract][Full Text] [Related]
15. Mucinous carcinoma of the ovary. Clinicopathologic analysis.
Kikkawa F; Kawai M; Tamakoshi K; Suganuma N; Nakashima N; Furuhashi Y; Kuzuya K; Hattori S; Arii Y; Tomoda Y
Oncology; 1996; 53(4):303-7. PubMed ID: 8692534
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma).
Koskas M; Uzan C; Gouy S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
Ann Surg Oncol; 2011 Jan; 18(1):40-8. PubMed ID: 20737216
[TBL] [Abstract][Full Text] [Related]
17. Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation.
Kim KR; Choi J; Hwang JE; Baik YA; Shim JY; Kim YM; Robboy SJ
Histopathology; 2010 Oct; 57(4):587-96. PubMed ID: 20955384
[TBL] [Abstract][Full Text] [Related]
18. Emergence of CA125 immunoreactivity in recurrent or metastatic primary ovarian mucinous neoplasms of the intestinal type.
Miller K; Millar J; McCluggage WG
Am J Surg Pathol; 2011 Sep; 35(9):1331-6. PubMed ID: 21836488
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and prognosis of mucinous tumors of the ovary.
Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
[TBL] [Abstract][Full Text] [Related]
20. Borderline ovarian tumors: features and controversial aspects.
Messalli EM; Grauso F; Balbi G; Napolitano A; Seguino E; Torella M
Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):86-9. PubMed ID: 23219291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]